Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mice with a keratinocyte-restricted deletion of the actin polymerization-promoting molecule, N-WASP, display cyclic hair loss and skin inflammation. Here, we showed that these mice were also resistant to 7,12-dimethylbenz(a)anthracene (DMBA)/12-
O
-tetradecanoylphorbol-13-acetate (TPA)-induced
skin tumor
formation. This resistance correlated with decreased expression of the senescence regulator, DNMT1, and increased expression of the senescence marker, p16Ink4a, in N-WASP-deficient epidermis. Moreover, primary N-WASP-null keratinocytes displayed a premature senescence phenotype
in vitro
. Expression and activation of
p53
, a major inducer of senescence, was not significantly altered in N-WASP-null keratinocytes. However, impairment of
p53
function effectively rescued the senescence phenotype, indicating that N-WASP was an inhibitor of
p53
-induced senescence. Mechanistically, N-WASP regulated senescence by preventing
p53
-dependent degradation of the H3K9 methyltransferases, G9a/GLP, and the DNA methyltransferase, DNMT1, which both control keratinocyte senescence. This pathway collaborated with other N-WASP-independent, senescence-promoting signaling downstream of
p53
and allowed the fine tuning of
p53
-induced senescence by N-WASP. Collectively, these data reveal N-WASP as an inhibitor of
p53
-induced senescence, which might be of importance for
skin tumor
formation and cellular aging of keratinocytes. SIGNIFICANCE: These findings demonstrate that N-WASP regulates
p53
-dependent senescence in keratinocytes
in vitro
and
in vivo
.
...
PMID:Negative Regulation of p53-Induced Senescence by N-WASP Is Crucial for DMBA/TPA-Induced Skin Tumor Formation. 3089 71
<< Previous
1
2
3
4
5
6
7
8